Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.

Hannes Vihinen, Artturi Jokinen,Teemu D Laajala,Nesna Wahid, Lotta Peltola, Tiia Kettunen,Aino Rönkä,Leena Tiainen,Tanja Skyttä,Laura Kohtamäki,Sanni Tulokas,Hanna Karhapää,Micaela Hernberg,Maria Silvoniemi,Kalle E Mattila

Clinical lung cancer（2023）

引用 1|浏览11

暂无评分

摘要

Early ABT was an independent poor risk factor in NSCLC patients who had received anti-PD-1/L1 monotherapy but not in melanoma patients. The weight of ABT as a poor risk factor might depend on other prognostic factors in different cancers.

查看译文

关键词

Antibiotics,Immune checkpoint inhibitors,Overall survival,Prognostic factor,Progression-free survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要